Igboeli Nneka U, Ukwe Chinwe V, Ekwunife Obinna I
Department of Clinical Pharmacy and Pharmacy Management. Faculty of Pharmaceutical Sciences, University of Nigeria . Nsukka ( Nigeria ).
Pharm Pract (Granada). 2010 Oct;8(4):243-9. doi: 10.4321/s1886-36552010000400007. Epub 2010 Mar 15.
This study aimed at describing the pattern of outpatient antimalarial drug prescribing in a secondary and a tertiary hospital, and to assess adherence to the National Antimalarial Treatment Guideline (ATG).
An audit of antimalarial prescription files from the two health facilities for a period of six months in 2008 was conducted. Semi structured questionnaires were used to collect information from the doctors and pharmacists on their awareness and knowledge of the National Antimalarial Treatment Guideline.
Artemisinin-based combination therapies (ACTs) were the most prescribed antimalarials. Overall, 81.4% of the total prescriptions contained ACTs, out of which 56.8% were artemetherlumefantrine. However, adherence to the drugs indicated by national guideline within the DU90% was 38.5% for the tertiary and 66.7 % for the secondary hospital. The standard practice of prescribing with generic name was still not adhered to as evidenced in the understudied hospitals. The percentage of health care providers that were aware of the ATG was 88.2% for doctors and 85.1% for pharmacists. However, 13.3% and 52.2% of doctors and pharmacists respectively could not properly list the drugs specified in the guideline. Amodiaquine was the most commonly preferred option for managing children aged 0 - 3 months with malaria infection against the indicated oral quinine.
This study showed an increased use of artemisinin-based combination therapy for the treatment of uncomplicated malaria compared previous reports in Nigeria. This study also highlights the need for periodic in-service quality assurance among health professionals with monitoring of adherence to and assessment of knowledge of clinical guidelines to ensure the practice of evidence based medicine.
本研究旨在描述一家二级医院和一家三级医院门诊抗疟药物的处方模式,并评估对《国家抗疟治疗指南》(ATG)的遵循情况。
对这两家医疗机构2008年为期六个月的抗疟处方档案进行了审核。使用半结构化问卷从医生和药剂师那里收集他们对《国家抗疟治疗指南》的认识和了解情况。
以青蒿素为基础的联合疗法(ACTs)是最常开具的抗疟药物。总体而言,所有处方中有81.4%包含ACTs,其中56.8%是蒿甲醚-本芴醇。然而,在三级医院中,遵循国家指南中DU90%范围内所指示药物的比例为38.5%,在二级医院中为66.7%。在所研究的医院中,开具通用名药物的标准做法仍未得到遵循。知晓ATG的医护人员比例,医生为88.2%,药剂师为85.1%。然而,分别有13.3%的医生和52.2%的药剂师不能正确列出指南中规定的药物。对于感染疟疾的0至3个月大儿童,与指示的口服奎宁相比,阿莫地喹是最常被选用的治疗药物。
本研究表明,与尼日利亚以前的报告相比,基于青蒿素的联合疗法在治疗非复杂性疟疾方面的使用有所增加。本研究还强调了对卫生专业人员进行定期在职质量保证的必要性,同时监测对临床指南的遵循情况并评估知识掌握情况,以确保循证医学的实践。